Precipio (PRPO) Stock Continues Skyward

Precipio PRPO Stock News

Precipio Inc (NASDAQ: PRPO) stock is headed for the top for the second consecutive session after the company announced the successful launch of its COVID-19 rapid antibody test. Here’s what’s happening: PRPO Announces COVID-19 Test Launch In the press release issued early yesterday morning, Precipio said that it has successfully launched its COVID-19 rapid antibody … Read more

Cocrystal Pharma (COCP) Stock Rockets On COVID-19 News

CoCrystal Pharma COCP Stock News

Cocrystal Pharma Inc (NASDAQ: COCP) is screaming for the top in the market this morning, following up on the gains we saw yesterday in a big way. The gains come after the company announced progress in developing broad-spectrum antiviral drug candidates for coronavirus infection. Here’s what’s happening: COCP Stock Gains On COVID-19 News In the … Read more

Ocugen (OCGN) Stock Climbs On COVAXIN Data

Ocugen OCGN Stock News

Ocugen Inc (NASDAQ: OCGN) is headed up in the market again this morning, and for good reason. The company announced that the vaccine its partnership with Bharat Biotech surrounds is showing compelling signs of efficacy against three key variants of COVID-19. Here’s what’s going on: OCGN Stock Gains On Vaccine Efficacy In the press release, … Read more

AMC Entertainment (AMC) Stock Highlights Corruption On Wall Street

AMC Entertainment AMC Stock News

I’ve been covering AMC Entertainment Holdings Inc (NYSE: AMC) stock, as I often do with stocks that the “experts” say are going to tank, with a contrarian opinion. I’ve received tons of emails. However, things have been very different this time around.  Usually, when I cover a stock that “the masses” believe will fall, and … Read more

Galera Therapeutics (GRTX) Is Rocketing On Positive Clinical Results

Galera Therapeutics GRTX Stock News

Galera Therapeutics Inc (NASDAQ: GRTX) is rocketing in the market this morning after announcing updated results from a trial of GC4419 in patients with advanced pancreatic cancer. Here’s what’s going on: Galera Therapeutics Announced Positive Clinical Results In a press release, Galera Therapeutics let investors in on new data from a Phase ½ pilot trial … Read more